Journal of Kerman University of Medical Sciences

Association between Rotavirus Infection and Irritable Bowel Syndrome: A Case-control Study in Kerman - Iran

Document Type : Original Article

Authors

Mostafa Aalipour 1
Mohammad Javad Zahedi 2
Mohammad Reza Zangouey 3
Abolfazl Yari 4
Moghaddameh Mirzaee 5
Mohammad Mahdi Mohammadi 3

1 Department of immunology, Afzalipour faculty of medicine, Kerman University of Medical Sciences, Kerman, Iran.

2 Department of Internal Medicine, Kerman University of Medical Sciences, Kerman, Iran

3 Department of immunology, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.

4 Cellular and Molecular research center. Birjand University of Medical Sciences, Birjand, Iran.

5 Department of Biostatistics and Epidemiology, School of Public Health, Kerman University of Medical Sciences, Kerman, Iran

https://doi.org/10.34172/jkmu.2023.55
Abstract
Background: Irritable bowel syndrome is a functional gastrointestinal disease of unknown etiology. Researchers have recently drawn attention to the possible role of viruses in the development of IBS and provided evidence in this regard. In this study, it was decided to investigate the possible role of rotavirus infection in the onset of IBS.
Methods: Stool and serum samples were collected from 40 patients with IBS and 40 healthy individuals. To evaluate the previous exposure to rotavirus we checked the presence and concentration of anti-rotavirus IgG by ELISA. ELISA test was performed on the serum samples. Real-time PCR test was also used to measure the viral load in the stool. Finally, the data were analyzed by SPSS-22 software.
Results: No significant relationship was found between anti-rotavirus IgG presence and Level in the serum of case and healthy individuals (p-value > 0.05) . Moreover, there was no significant difference between the viral genome load in the stool samples of the two groups (p-value > 0.05).
Conclusion: According to the results, it seems unlikely that a link exists between rotavirus infection and the onset of irritable bowel syndrome, but the possible role of other gastrointestinal viruses, including coronavirus, remains.

Highlights

Mostafa Aalipour(google scholar)(pubmed)

Mohammad Javad Zahedi(google scholar)(pubmed)

Mohammad Reza Zangouey(google scholar)(pubmed)

Abolfazl Yari(google scholar)(pubmed)

Moghaddameh Mirzaee(google scholar)(pubmed)

Mohammad Mahdi Mohammadi(google scholar)(pubmed)

Keywords

Irritable Bowel Syndrome
Rotavirus
Pattern Recognition Receptors
Coronavirus
Subjects
  1. Barbara G, Cremon C, Annese V, Basilisco G, Bazzoli F, Bellini M, et al. Randomised controlled trial of mesalazine in IBS. Gut. 2016;65(1):82-90. doi: 1136/gutjnl-2014-308188.
  2. Lembo AJ, Lacy BE, Zuckerman MJ, Schey R, Dove LS, Andrae DA, et al. Eluxadoline for irritable bowel syndrome with diarrhea. N Engl J Med. 2016;374(3):242-53. doi: 1056/ NEJMoa1505180.
  3. Thompson JR. Is irritable bowel syndrome an infectious disease? World J Gastroenterol. 2016;22(4):1331-4. doi: 3748/wjg.v22.i4.1331.
  4. Jahangiri P, Hashemi Jazi MS, Hassanzadeh Keshteli A, Sadeghpour S, Amini E, Adibi P. Irritable bowel syndrome in Iran: SEPAHAN systematic review No. 1. Int J Prev Med. 2012;3(Suppl 1):S1-9.
  5. Hayatbakhsh M, Zahedi MJ, Darvish Moghadam S, Seyed Mirzaei SM, Najafipor H, Haghdost AA, et al. The prevalence of irritable bowel syndrome, and its clinical symptoms and related factors among the adult population of Kerman, Iran. J Kerman Univ Med Sci. 2013;20(5):331-42. [Persian].
  6. Foxx-Orenstein A. IBS--review and what’s new. MedGenMed. 2006;8(3):20.
  7. Addante R, Naliboff B, Shih W, Presson AP, Tillisch K, Mayer EA, et al. Predictors of health-related quality of life in irritable bowel syndrome patients compared with healthy individuals. J Clin Gastroenterol. 2019;53(4):e142-9. doi: 1097/ mcg.0000000000000978.
  8. Canavan C, West J, Card T. Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther. 2014;40(9):1023-34. doi: 1111/apt.12938.
  9. Dlugosz A, Zakikhany K, Acevedo N, D’Amato M, Lindberg G. Increased expression of toll-like receptors 4, 5, and 9 in small bowel mucosa from patients with irritable bowel syndrome. Biomed Res Int. 2017;2017:9624702. doi: 1155/2017/9624702.
  10. Swan C, Duroudier NP, Campbell E, Zaitoun A, Hastings M, Dukes GE, et al. Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα. Gut. 2013;62(7):985- 94. doi: 1136/gutjnl-2011-301213.
  11. Norlin AK, Walter S, Theodorsson E, Tegelstrom V, Grodzinsky E, Jones MP, et al. Cortisol levels in hair are altered in irritable bowel syndrome - a case control study in primary care. J Psychosom Res. 2017;93:69-75. doi: 1016/j.jpsychores.2016.12.009.
  12. Salvioli B, Pellegatta G, Malacarne M, Pace F, Malesci A, Pagani M, et al. Autonomic nervous system dysregulation in irritable bowel syndrome. Neurogastroenterol Motil. 2015;27(3):423-30. doi: 1111/nmo.12512.
  13. Katsumata R, Ishii M, Lee S, Handa Y, Murao T, Fujita M, et al. Cytokine profile and immunoglobulin E-mediated serological food hypersensitivity in patients with irritable bowel syndrome with diarrhea. J Neurogastroenterol Motil. 2018;24(3):415-21. doi: 5056/jnm17114.
  14. De Palma G, Lynch MD, Lu J, Dang VT, Deng Y, Jury J, et al. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Sci Transl Med. 2017;9(379):eaaf6397. doi: 1126/scitranslmed.aaf6397.
  15. Pender MP, Burrows SR. Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy. Clin Transl Immunology. 2014;3(10):e27. doi: 1038/ cti.2014.25.
  16. Hanlon P, Avenell A, Aucott L, Vickers MA. Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus. Arthritis Res Ther. 2014;16(1):R3. doi: 1186/ar4429.
  17. Balandraud N, Roudier J. Epstein-Barr virus and rheumatoid arthritis. Joint Bone Spine. 2018;85(2):165-70. doi: 1016/j. jbspin.2017.04.011.
  18. Cao-Lormeau VM, Blake A, Mons S, Lastère S, Roche C, Vanhomwegen J, et al. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387(10027):1531-9. doi: 1016/s0140-6736(16)00562-6.
  19. Chyzheuskaya I, Belyaeva L, Filonovich R, Zaitseva L, Lyatun A. Infectious agents in juvenile scleroderma. Pediatr Rheumatol. 2014;12(1):P306. doi: 1186/1546-0096-12- S1-P306.
  20. Wang W, Jovel J, Halloran B, Wine E, Patterson J, Ford G, et al. Metagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteria. Inflamm Bowel Dis. 2015;21(6):1419- 27. doi: 1097/mib.0000000000000344.
  21. Aalipour M, Yari A, Zahedi MJ, Mohammadi MM. Evaluation of toll-like receptor alteration in intestinal biopsies of patients with irritable bowel syndrome: a systematic review. Govaresh. 2019;24(2):104-10.
  22. Desselberger U. Rotaviruses. Virus Res. 2014;190:75-96. doi: 1016/j.virusres.2014.06.016.
  23. Velázquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, et al. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med. 1996;335(14):1022-8. doi: 1056/nejm199610033351404.
  24. Kumar A, Basu S, Vashishtha V, Choudhury P. Burden of rotavirus diarrhea in under five Indian children. Indian Pediatr. 2016;53(7):607-17. doi: 1007/s13312-016-0896-y.
  25. Ahmadi E, Alizadeh-Navaei R, Rezai MS. Efficacy of probiotic use in acute rotavirus diarrhea in children: a systematic review and meta-analysis. Caspian J Intern Med. 2015;6(4):187-95.
  26. Nan X, Jinyuan W, Yan Z, Maosheng S, Hongjun L. Epidemiological and clinical studies of rotavirus-induced diarrhea in China from 1994-2013. Hum Vaccin Immunother. 2014;10(12):3672-80. doi: 4161/21645515.2014.979691.
  27. Yang M, Lee G, Si J, Lee SJ, You HJ, Ko G. Curcumin shows antiviral properties against norovirus. Molecules. 2016;21(10):1401. doi: 3390/molecules21101401.
  28. World Health Organization (WHO). Manual of Rotavirus Detection and Characterization Methods. WHO; 2009.
  29. Akiho H, Ihara E, Nakamura K. Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J Gastrointest Pathophysiol. 2010;1(3):97- 105. doi: 4291/wjgp.v1.i3.97.
  30. Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2012;107(10):1474-82. doi: 1038/ajg.2012.260.
  31. Fairbrass KM, Costantino SJ, Gracie DJ, Ford AC. Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(12):1053-62. doi: 1016/s2468-1253(20)30300-9.
  32. Lopetuso LR, Petito V, Graziani C, Schiavoni E, Paroni Sterbini F, Poscia A, et al. Gut microbiota in health, diverticular disease, irritable bowel syndrome, and inflammatory bowel diseases: time for microbial marker of gastrointestinal disorders. Dig Dis. 2018;36(1):56-65. doi: 1159/000477205.

Svendsen AT, Bytzer P, Engsbro AL. Systematic review

with meta-analyses: does the pathogen matter in post-infectious irritable bowel syndrome? Scand J Gastroenterol. 2019;54(5):546-62. doi: 10.1080/00365521.2019.1607897.

  1. Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther. 2018;48(10):1044- 60. doi: 10.1111/apt.15001.
  2. Dale HF, Rasmussen SH, Asiller ÖÖ, Lied GA. Probiotics in irritable bowel syndrome: an up-to-date systematic review. Nutrients. 2019;11(9):2048. doi: 10.3390/nu11092048.
  3. Shariati A, Fallah F, Pormohammad A, Taghipour A, Safari H, Salami Chirani A, et al. The possible role of bacteria, viruses, and parasites in initiation and exacerbation of irritable bowel syndrome. J Cell Physiol. 2019;234(6):8550-69. doi: 10.1002/ jcp.27828.
  4. Marshall JK, Thabane M, Borgaonkar MR, James C. Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin Gastroenterol Hepatol. 2007;5(4):457-60. doi: 10.1016/j.cgh.2006.11.025.
  5. Zanini B, Ricci C, Bandera F, Caselani F, Magni A, Laronga AM, et al. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak. Am J Gastroenterol. 2012;107(6):891-9. doi: 10.1038/ajg.2012.102.
  6. Alzahrani MA, Alshamrani AS, Ahmasani IM, Alahmari FS, Asiri AH, Alshehri AM, et al. Coronavirus disease 2019 pandemic stress and its effects on irritable bowel syndrome patients in Saudi Arabia. Medicine (Baltimore). 2020;99(51):e23711. doi: 10.1097/md.0000000000023711.
  7. Oshima T, Siah KTH, Yoshimoto T, Miura K, Tomita T, Fukui H, et al. Impacts of the COVID-19 pandemic on functional dyspepsia and irritable bowel syndrome: a population-based survey. J Gastroenterol Hepatol. 2021;36(7):1820-7. doi: 10.1111/jgh.15346.
  8. Quek SXZ, Loo EXL, Demutska A, Chua CE, Kew GS, Wong S, et al. Impact of the coronavirus disease 2019 pandemic on irritable bowel syndrome. J Gastroenterol Hepatol. 2021;36(8):2187-97. doi: 10.1111/jgh.15466.
  9. Ilie OD, Ilinca-Bianca NI, Cojocariu RO, Balmus IM, Ciobica A, Doroftei B, et al. Studying some possible irritable bowel syndrome manifestations in COVID-19 patients. Med Surg J. 2021;125(2):199-208.
  10. Podkolzin AT, Fenske EB, Abramycheva NY, Shipulin GA, Sagalova OI, Mazepa VN, et al. Hospital-based surveillance of rotavirus and other viral agents of diarrhea in children and adults in Russia, 2005-2007. J Infect Dis. 2009;200 Suppl 1:S228-33. doi: 10.1086/605054.
  11. Niendorf S, Ebner W, Marques AM, Bierbaum S, Babikir R, Huzly D, et al. Rotavirus outbreak among adults in a university hospital in Germany. J Clin Virol. 2020;129:104532. doi: 10.1016/j.jcv.2020.104532.
  12. Satayarak J, Strauss ST, Duangdee C, Charunwatthana P, Jiamsomboon K, Kosoltanapiwat N, et al. Prevalence and diversity of human rotavirus among Thai adults. J Med Virol. 2020;92(11):2582-92. doi: 10.1002/jmv.26076.
  13. Camilleri M, Carlson P, Valentin N, Acosta A, O’Neill J, Eckert D, et al. Pilot study of small bowel mucosal gene expression in patients with irritable bowel syndrome with diarrhea. Am J Physiol Gastrointest Liver Physiol. 2016;311(3):G365-76. doi: 10.1152/ajpgi.00037.2016.
  14. Jiang B, Gentsch JR, Glass RI. The role of serum antibodies in the protection against rotavirus disease: an overview. Clin Infect Dis. 2002;34(10):1351-61. doi: 10.1086/340103.
  15. Rizzo AG, Orlando A, Gallo E, Bisanti A, Sferrazza S, Montalbano LM, et al. Is Epstein-Barr virus infection associated with the pathogenesis of microscopic colitis? J Clin Virol. 2017;97:1-3. doi: 10.1016/j.jcv.2017.10.009.
  16. Ciccocioppo R, Racca F, Scudeller L, Piralla A, Formagnana P, Pozzi L, et al. Differential cellular localization of Epstein- Barr virus and human cytomegalovirus in the colonic mucosa of patients with active or quiescent inflammatory bowel disease. Immunol Res. 2016;64(1):191-203. doi: 10.1007/ s12026-015-8737-y.
  17. Azami M, Badfar G, Abangah G, Mahmoudi L. Celiac disease in Iranian irritable bowel syndrome patients; a systematic review and meta-analysis. Gastroenterol Hepatol Bed Bench. 2019;12(2):85-97.

 

 

Journal of Kerman University of Medical Sciences
Volume 30, Issue 6 - Serial Number 6
November and December 2023
Pages 327-332

Home

Editorial Board

Guide for Authors

Submit Manuscript

Guide for Reviewers

Contact Us